Literature DB >> 27446990

Impact of early cART in the gut during acute HIV infection.

Claire Deleage1, Alexandra Schuetz2, W Gregory Alvord3, Leslie Johnston1, Xing-Pei Hao4, David R Morcock1, Rungsun Rerknimitr5, James L K Fletcher6, Suwanna Puttamaswin6, Nittaya Phanuphak6, Robin Dewar7, Joseph M McCune8, Irini Sereti9, Merlin Robb10, Jerome H Kim11, Timothy W Schacker12, Peter Hunt13, Jeffrey D Lifson1, Jintanat Ananworanich14, Jacob D Estes1.   

Abstract

Early after HIV infection there is substantial depletion of CD4+ T cells in the gastrointestinal (GI) tract lamina propria (LP), with associated epithelial barrier damage, leading to microbial translocation and systemic inflammation and immune activation. In this study, we analyzed these early events in the GI tract in a cohort of Thai acute HIV-infected patients and determined the effect of early combination antiretroviral treatment (cART). HIV-uninfected and chronically and acutely HIV-infected patients at different Fiebig stages (I-V) underwent colonic biopsies and then received cART. Immunohistochemistry and quantitative image analysis were performed on cross-sectional and longitudinal colon biopsy specimens (day 0 to week 96) to measure GI tract damage (infiltration of polymorphonuclear cells), inflammation (M×1, TNF-α), immune activation (Ki-67), and the CD4+ T cell population in the LP. The magnitude of GI tract damage, immune activation, and inflammation was significantly increased, with significantly depleted CD4+ T cells in the LP in all acutely infected groups prior to cART compared with HIV-uninfected control participants. While most patients treated during acute infection resolved GI tract inflammation and immune activation back to baseline levels after 24 weeks of cART, most acutely infected participants did not restore their CD4+ T cells after 96 weeks of cART.

Entities:  

Year:  2016        PMID: 27446990      PMCID: PMC4951101          DOI: 10.1172/jci.insight.87065

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  68 in total

1.  Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with <50copies/ml HIV-1 RNA.

Authors:  Silvia Baroncelli; Clementina Maria Galluzzo; Maria Franca Pirillo; Maria Grazia Mancini; Liliana Elena Weimer; Mauro Andreotti; Roberta Amici; Stefano Vella; Marina Giuliano; Lucia Palmisano
Journal:  J Clin Virol       Date:  2009-09-25       Impact factor: 3.168

Review 2.  Th17 cells, HIV and the gut mucosal barrier.

Authors:  Satya Dandekar; Michael D George; Andreas J Bäumler
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

3.  Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus.

Authors:  Y Klipper-Aurbach; M Wasserman; N Braunspiegel-Weintrob; D Borstein; S Peleg; S Assa; M Karp; Y Benjamini; Y Hochberg; Z Laron
Journal:  Med Hypotheses       Date:  1995-11       Impact factor: 1.538

4.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Authors:  Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

Review 5.  Residual inflammation and viral reservoirs: alliance against an HIV cure.

Authors:  Marta Massanella; Rémi Fromentin; Nicolas Chomont
Journal:  Curr Opin HIV AIDS       Date:  2016-03       Impact factor: 4.283

6.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

7.  Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008.

Authors:  Nikolas Wada; Lisa P Jacobson; Mardge Cohen; Audrey French; John Phair; Alvaro Muñoz
Journal:  Am J Epidemiol       Date:  2013-01-03       Impact factor: 4.897

8.  The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

Authors:  J L Fahey; J M Taylor; R Detels; B Hofmann; R Melmed; P Nishanian; J V Giorgi
Journal:  N Engl J Med       Date:  1990-01-18       Impact factor: 91.245

9.  Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection.

Authors:  N R Klatt; J D Estes; X Sun; A M Ortiz; J S Barber; L D Harris; B Cervasi; L K Yokomizo; L Pan; C L Vinton; B Tabb; L A Canary; Q Dang; V M Hirsch; G Alter; Y Belkaid; J D Lifson; G Silvestri; J D Milner; M Paiardini; E K Haddad; J M Brenchley
Journal:  Mucosal Immunol       Date:  2012-05-30       Impact factor: 7.313

10.  Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients.

Authors:  Petronela Ancuta; Anupa Kamat; Kevin J Kunstman; Eun-Young Kim; Patrick Autissier; Alysse Wurcel; Tauheed Zaman; David Stone; Megan Mefford; Susan Morgello; Elyse J Singer; Steven M Wolinsky; Dana Gabuzda
Journal:  PLoS One       Date:  2008-06-25       Impact factor: 3.240

View more
  33 in total

1.  Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection.

Authors:  Louise Leyre; Eugène Kroon; Claire Vandergeeten; Carlo Sacdalan; Donn J Colby; Supranee Buranapraditkun; Alexandra Schuetz; Nitiya Chomchey; Mark de Souza; Wendy Bakeman; Rémi Fromentin; Suteeraporn Pinyakorn; Siriwat Akapirat; Rapee Trichavaroj; Suthat Chottanapund; Sopark Manasnayakorn; Rungsun Rerknimitr; Phandee Wattanaboonyoungcharoen; Jerome H Kim; Sodsai Tovanabutra; Timothy W Schacker; Robert O'Connell; Victor G Valcour; Praphan Phanuphak; Merlin L Robb; Nelson Michael; Lydie Trautmann; Nittaya Phanuphak; Jintanat Ananworanich; Nicolas Chomont
Journal:  Sci Transl Med       Date:  2020-03-04       Impact factor: 17.956

2.  Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.

Authors:  Irini Sereti; Shelly J Krebs; Nittaya Phanuphak; James L Fletcher; Bonnie Slike; Suteeraporn Pinyakorn; Robert J O'Connell; Adam Rupert; Nicolas Chomont; Victor Valcour; Jerome H Kim; Merlin L Robb; Nelson L Michael; Daniel C Douek; Jintanat Ananworanich; Netanya S Utay
Journal:  Clin Infect Dis       Date:  2016-10-12       Impact factor: 9.079

Review 3.  Gut reactions: How the blood-brain barrier connects the microbiome and the brain.

Authors:  Aric F Logsdon; Michelle A Erickson; Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-23

4.  Kynurenine 3-Monooxygenase Inhibition during Acute Simian Immunodeficiency Virus Infection Lowers PD-1 Expression and Improves Post-Combination Antiretroviral Therapy CD4+ T Cell Counts and Body Weight.

Authors:  Louise A Swainson; Haelee Ahn; Priya Pajanirassa; Vinod Khetarpal; Claire Deleage; Jacob D Estes; Peter W Hunt; Ignacio Munoz-Sanjuan; Joseph M McCune
Journal:  J Immunol       Date:  2019-07-08       Impact factor: 5.422

Review 5.  HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration.

Authors:  Ivan Vujkovic-Cvijin; Ma Somsouk
Journal:  Curr HIV/AIDS Rep       Date:  2019-06       Impact factor: 5.071

6.  TLR7 agonist administration to SIV-infected macaques receiving early initiated cART does not induce plasma viremia.

Authors:  Gregory Q Del Prete; W Gregory Alvord; Yuan Li; Claire Deleage; Mukta Nag; Kelli Oswald; James A Thomas; Cathi Pyle; William J Bosche; Vicky Coalter; Adam Wiles; Rodney Wiles; Brian Berkemeier; Michael Hull; Elizabeth Chipriano; Lorna Silipino; Randy Fast; Jacob Kiser; Rebecca Kiser; Tyler Malys; Joshua Kramer; Matthew W Breed; Charles M Trubey; Jacob D Estes; Tiffany L Barnes; Joseph Hesselgesser; Romas Geleziunas; Jeffrey D Lifson
Journal:  JCI Insight       Date:  2019-06-06

7.  Antiretroviral Therapy Administration in Healthy Rhesus Macaques Is Associated with Transient Shifts in Intestinal Bacterial Diversity and Modest Immunological Perturbations.

Authors:  Alexandra M Ortiz; Jacob K Flynn; Sarah R DiNapoli; Ornella Sortino; Ivan Vujkovic-Cvijin; Yasmine Belkaid; Irini Sereti; Jason M Brenchley
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

8.  Antibody-mediated depletion of viral reservoirs is limited in SIV-infected macaques treated early with antiretroviral therapy.

Authors:  Adrienne E Swanstrom; Taina T Immonen; Kelli Oswald; Cathi Pyle; James A Thomas; William J Bosche; Lorna Silipino; Michael Hull; Laura Newman; Vicky Coalter; Adam Wiles; Rodney Wiles; Jacob Kiser; David R Morcock; Rebecca Shoemaker; Randy Fast; Matthew W Breed; Joshua Kramer; Duncan Donohue; Tyler Malys; Christine M Fennessey; Charles M Trubey; Claire Deleage; Jacob D Estes; Jeffrey D Lifson; Brandon F Keele; Gregory Q Del Prete
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

9.  Mass cytometry identifies distinct CD4+ T cell clusters distinguishing HIV-1-infected patients according to antiretroviral therapy initiation.

Authors:  Yonas Bekele; Tadepally Lakshmikanth; Yang Chen; Jaromir Mikes; Aikaterini Nasi; Stefan Petkov; Bo Hejdeman; Petter Brodin; Francesca Chiodi
Journal:  JCI Insight       Date:  2019-02-07

Review 10.  Tissue issues: mucosal T-cell responses in HIV-1 infection.

Authors:  Barbara L Shacklett; April L Ferre; Brenna E Kiniry
Journal:  Curr Opin HIV AIDS       Date:  2019-03       Impact factor: 4.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.